Additionally, the knocking down of NF‐κB suppressed the EGFRvIII overexpressing glioma cell bearing‐tumour growth in vivo with the inhibition of angiogenesis, indicating the crucial role of NF‐κB in EGFRvIII enhancing the carcinogenic capacity126 (Table 1). The gene discussed is NFKB1; the disease is glioma.